Cargando…

Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center

Detalles Bibliográficos
Autores principales: Göker, Hakan, Çınar, Olgu Erkin, Demiroğlu, Haluk, Malkan, Ümit Yavuz, Aladağ Karakulak, Elifcan, Büyükaşık, Yahya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476247/
https://www.ncbi.nlm.nih.gov/pubmed/37314288
http://dx.doi.org/10.4274/tjh.galenos.2023.2023.0089
_version_ 1785100886794567680
author Göker, Hakan
Çınar, Olgu Erkin
Demiroğlu, Haluk
Malkan, Ümit Yavuz
Aladağ Karakulak, Elifcan
Büyükaşık, Yahya
author_facet Göker, Hakan
Çınar, Olgu Erkin
Demiroğlu, Haluk
Malkan, Ümit Yavuz
Aladağ Karakulak, Elifcan
Büyükaşık, Yahya
author_sort Göker, Hakan
collection PubMed
description
format Online
Article
Text
id pubmed-10476247
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-104762472023-09-05 Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center Göker, Hakan Çınar, Olgu Erkin Demiroğlu, Haluk Malkan, Ümit Yavuz Aladağ Karakulak, Elifcan Büyükaşık, Yahya Turk J Haematol Letters to the Editor Galenos Publishing 2023-09 2023-08-31 /pmc/articles/PMC10476247/ /pubmed/37314288 http://dx.doi.org/10.4274/tjh.galenos.2023.2023.0089 Text en © Copyright 2023 by Turkish Society of Hematology / Turkish Journal of Hematology, Published by Galenos Publishing House. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Göker, Hakan
Çınar, Olgu Erkin
Demiroğlu, Haluk
Malkan, Ümit Yavuz
Aladağ Karakulak, Elifcan
Büyükaşık, Yahya
Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center
title Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center
title_full Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center
title_fullStr Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center
title_full_unstemmed Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center
title_short Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center
title_sort venetoclax and azacitidine treatment in relapsed acute myeloid leukemia after hematopoietic stem cell transplantation: a cohort study in the real-world setting of a tertiary center
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476247/
https://www.ncbi.nlm.nih.gov/pubmed/37314288
http://dx.doi.org/10.4274/tjh.galenos.2023.2023.0089
work_keys_str_mv AT gokerhakan venetoclaxandazacitidinetreatmentinrelapsedacutemyeloidleukemiaafterhematopoieticstemcelltransplantationacohortstudyintherealworldsettingofatertiarycenter
AT cınarolguerkin venetoclaxandazacitidinetreatmentinrelapsedacutemyeloidleukemiaafterhematopoieticstemcelltransplantationacohortstudyintherealworldsettingofatertiarycenter
AT demirogluhaluk venetoclaxandazacitidinetreatmentinrelapsedacutemyeloidleukemiaafterhematopoieticstemcelltransplantationacohortstudyintherealworldsettingofatertiarycenter
AT malkanumityavuz venetoclaxandazacitidinetreatmentinrelapsedacutemyeloidleukemiaafterhematopoieticstemcelltransplantationacohortstudyintherealworldsettingofatertiarycenter
AT aladagkarakulakelifcan venetoclaxandazacitidinetreatmentinrelapsedacutemyeloidleukemiaafterhematopoieticstemcelltransplantationacohortstudyintherealworldsettingofatertiarycenter
AT buyukasıkyahya venetoclaxandazacitidinetreatmentinrelapsedacutemyeloidleukemiaafterhematopoieticstemcelltransplantationacohortstudyintherealworldsettingofatertiarycenter